BARCELONA, Spain–(BUSINESS WIRE)–REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker innovation, has unveiled groundbreaking research that highlights a significant, previously unrecognized link between an anti-tumor adaptive immune response and improved survival outcomes in individuals who have apparently overcome breast cancer. This study highlights the clinical value of REVEAL GENOMICS®’ immune gene combinations, whic
Go to Source
Author: